The diagnosis of diffuse astrocytoma or oligodendroglioma (grade 2–3), traditionally based solely on histomorphological criteria, now requires the demonstration of the presence of the IDH1 or IDH2 mutation and, in the case of oligodendrogliomas, of the 1p/19q codeletion [3,4]. The gene discussed is IDH1; the disease is oligodendroglioma.